Recognising and managing depression (mhGAP)
A practical teaching session for nurses, clinical officers, doctors and supervised community workers who see people with depression in general clinics. It uses the WHO mhGAP Intervention Guide and the 2023 mhGAP guideline, and relies on role-play so participants practise the words, not just the facts. It links to the free online course for a CPD certificate.
- 120 minutes
- For nurses, clinical officers, doctors and supervised community health workers
- Group: 8 to 24 participants, in groups of 3
- Goes with the course Mental health essentials (mhGAP)
Learning objectives
By the end of the session participants can:
- Use mhGAP communication skills to help a person talk about their mood.
- Assess depression with the mhGAP criteria and rule out physical causes, mania and normal grief.
- Ask directly and safely about self-harm and suicide, and act on imminent risk.
- Agree a treatment plan with psychoeducation, psychosocial support, psychological treatment and, where needed, an antidepressant.
- Plan follow-up.
Before the session
- Print the depression algorithm from mhGAP-IG 2.0 (or your national version), one per group.
- Print the role-play cards (cases below) and the handout, one per participant.
- Find out which psychological interventions (for example PM+, group IPT, problem-solving) and which antidepressants are available locally.
- Agree with the group at the start that personal stories shared in the room stay in the room.
Materials
- Flip chart or board and markers
- Printed role-play cards, mhGAP depression algorithm and handouts
- Chairs arranged in groups of 3 (person, health worker, observer)
Session plan
| Time | Activity | Method | Length |
|---|---|---|---|
| 0:00–0:10 | Welcome and ground rules Introductions and confidentiality. Ask: "How do people in our community describe depression?" Write the local words up; they will be used in the role-plays. | Whole group | 10 min |
| 0:10–0:25 | Communication essentials Private space, confidentiality, listening without interrupting, open questions, being non-judgemental. Facilitator shows a poor and then a good opening to a consultation; the group spots the differences. | Short talk and demonstration | 15 min |
| 0:25–0:50 | Assessing depression Health worker uses the algorithm: core symptom for 2 weeks, other symptoms, functioning; then physical causes, mania, recent loss. Observer uses the handout checklist. Rotate once. | Triads, role-play case 1 | 25 min |
| 0:50–1:10 | Asking about self-harm Facilitator models asking directly. Every participant says the question aloud once. Then triads practise case 2 and decide the level of risk and actions. | Whole group drill, then triads with case 2 | 20 min |
| 1:10–1:35 | Making a treatment plan Groups agree psychoeducation messages, social support, activity plan, psychological treatment and whether to add an antidepressant, with dose and duration. Feed back; highlight the 2023 guidance and special populations. | Groups, case 3 | 25 min |
| 1:35–1:50 | Follow-up and when to consult Second visit within 1 week; monthly contact for 3 months; antidepressants 9 to 12 months after recovery; stop if mania; consult if no improvement, psychosis, pregnancy or suicide risk. | Short talk and discussion | 15 min |
| 1:50–2:00 | Quiz and close Ten questions, answers discussed. Each participant writes the exact words they will use to ask about suicide. Point to the online course and certificate. | Individual, then whole group | 10 min |
Facilitator notes
Key messages to land
- Depression is common, often presents with physical complaints, and is treatable in general clinics.
- Use the three-part check: core symptom for 2 weeks, other symptoms, difficulty functioning.
- Always look for physical causes and ask about mania before treating.
- Asking about suicide does not provoke it. Ask everyone with depression.
- Psychological treatment first where available; an antidepressant alone only where it is not.
- Follow up within 1 week; continue antidepressants for 9 to 12 months after recovery.
Running the role-plays
- Keep triads to 3 people: person, health worker and observer. Give the observer a clear checklist so feedback is specific.
- Remind participants they are playing a role. Allow anyone to step out, and be ready to support a participant who becomes upset.
- Encourage the use of local words for distress, as long as the health worker still checks the mhGAP criteria.
Common misunderstandings
- "Asking about suicide will put the idea in their head"
- mhGAP is clear: asking does not provoke self-harm and often brings relief.
- "Depression is weakness"
- It is a common illness. Saying so is part of psychoeducation.
- "Stop the tablets when they feel better"
- Continue for 9 to 12 months after recovery, then taper over at least 4 weeks.
- "Vitamin injections help"
- They do not treat depression; mhGAP advises against ineffective treatments.
Adapting the session
If no psychological intervention is available locally, spend part of the treatment-planning time on what the team can offer (problem-solving steps, behavioural activation through planned daily activities) and on how to advocate for training. In humanitarian settings, add the mhGAP Humanitarian Intervention Guide and link to the self-harm and suicide protocol.
Case discussions (with answers)
Case 1: Role-play 1: Mrs W, 'pain everywhere'
Mrs W, 38, has come four times with headaches and body pains. Tests were normal. On open questioning she says she has felt sad nearly every day since her husband left eight months ago, sleeps badly, has no appetite, feels worthless, and has stopped selling at the market. She has never had periods of unusual energy. She has no thyroid symptoms, is not anaemic and takes no regular medicines.
- Does she meet the mhGAP criteria for depression?Answer: Yes: depressed mood for more than 2 weeks, several other symptoms (sleep, appetite, worthlessness), and difficulty functioning (stopped working). Her loss was eight months ago, more than six months, and physical causes and mania have been considered.
- What must the health worker ask next?Answer: About thoughts, plans or acts of self-harm or suicide, and about alcohol or other substance use.
Case 2: Role-play 2: Mr X, 'better off without me'
Mr X, 52, a farmer with depression, says his family would be better off without him. When asked, he says he has thought of drinking the pesticide stored in his shed, maybe this week. He is calm but tearful.
- What level of risk is this?Answer: Imminent risk of self-harm: a current plan with a method available.
- What do you do?Answer: Do not leave him alone; ask a named family member or staff to stay with him; with his agreement involve the family to remove the pesticide and any stored medicines; offer a quiet safe space; consult a mental health specialist if available; treat the depression; arrange very close follow-up (daily or weekly at first).
Case 3: Planning treatment: Ms Y, 29, after birth
Ms Y had a baby 3 months ago and is breastfeeding. She has moderate depression without thoughts of self-harm. A trained community worker runs Thinking Healthy sessions nearby.
- What is the first-line plan?Answer: Psychoeducation for her and her family, practical support with the baby and sleep, keeping up activities, and referral to Thinking Healthy (a CBT-based programme for perinatal depression). Follow up within 1 week.
- If she does not improve and an antidepressant is considered, what are the cautions?Answer: Avoid antidepressants in breastfeeding if possible; if needed, use the lowest effective dose and avoid long-acting fluoxetine while breastfeeding; consult a specialist if available.
End-of-session quiz
Read the questions aloud or print them. Participants choose one answer each. The answer key with reasons follows.
- How long must the core symptom of depression be present?
- 2 days
- At least 2 weeks
- 6 months
- 1 year
- Which is NOT a core symptom of depression in mhGAP?
- Persistent depressed mood
- Markedly reduced interest or pleasure
- Hearing voices
- Before treating depression, what must you rule out?
- Physical causes, a history of mania, and normal grief after a recent loss
- Nothing
- Only pregnancy
- Only alcohol use
- Does asking about suicide increase the risk?
- Yes
- No; it often reduces anxiety
- Only in adolescents
- A man has a plan to end his life this week. Which action is essential?
- Give a 3-month supply of tablets
- Remove means and do not leave him alone
- Advise rest and review in a month
- Tell him not to talk about it
- What does the 2023 mhGAP guideline say about antidepressant alone for moderate to severe depression?
- Always first choice
- Only when psychological interventions are not available
- Never use
- Which is a structured psychological treatment recommended for depression?
- Vitamin injections
- Behavioural activation or problem-solving therapy
- Bed rest
- Which antidepressant should not be used in a person with heart disease?
- Fluoxetine
- Amitriptyline
- Both are equally safe
- When should the second appointment be?
- Within 1 week
- In 6 months
- Only if the person asks
- How long should antidepressants usually continue after symptoms resolve?
- 2 weeks
- 9 to 12 months
- 5 years
Answer key
- B. Depressed mood or loss of interest for at least 2 weeks, with other symptoms and difficulty functioning.
- C. The two core symptoms are depressed mood and loss of interest or pleasure. Hallucinations suggest psychosis.
- A. Physical conditions, bipolar disorder (mania) and a major loss within 6 months must be considered.
- B. mhGAP: asking does not provoke self-harm.
- B. Imminent risk: remove means, never leave the person alone, consult if possible.
- B. Psychological or combined treatment; antidepressant alone only when psychological interventions are unavailable.
- B. Behavioural activation, problem-solving therapy, IPT and CBT are among the structured interventions.
- B. mhGAP: do not prescribe amitriptyline with cardiovascular disease.
- A. Schedule the second appointment within 1 week, then regular contact.
- B. 9 to 12 months, then taper over at least 4 weeks.
Sources
- World Health Organization. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0. 2016 (ISBN 9789241549790).
- World Health Organization. Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders. 2023 (ISBN 9789240084278).
- World Health Organization. mhGAP evidence centre: depression recommendations (2023 update). 2023.